Clinical ink Early Look

N/A

Published by: Clinical Ink
Downloads
Revenue

Description

Clinical Ink is the leader in virtual clinical trial conduct and the platform enables each customer to define the setup that works best for their trial.

Screenshots

Clinical ink Early Look FAQ

  • Is Clinical ink Early Look free?

    Yes, Clinical ink Early Look is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Clinical ink Early Look legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Clinical ink Early Look cost?

    Clinical ink Early Look is free.

  • What is Clinical ink Early Look revenue?

    To get estimated revenue of Clinical ink Early Look app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Russia yet.
Ratings History

Clinical ink Early Look Reviews

No Reviews in Russia
App doesn't have any reviews in Russia yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Clinical ink Early Look Installs

Last 30 days

Clinical ink Early Look Revenue

Last 30 days

Clinical ink Early Look Revenue and Downloads

Gain valuable insights into Clinical ink Early Look performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Publisher
Clinical Ink
Languages
Afrikaans, Arabic, Bengali, Bulgarian, Croatian, Czech, Danish, Dutch, English, Estonian, Finnish, French, Georgian, German, Greek (modern), Gujarati, Hebrew (modern), Hindi, Hungarian, Italian, Japanese, Kannada, Korean, Lithuanian, Malay, Malayalam, Marathi, Norwegian Bokmål, Norwegian Nynorsk, Polish, Portuguese, Panjabi, Romanian, Russian, Serbian, Southern Sotho, Chinese, Slovak, Spanish, Swedish, Tamil, Telugu, Thai, Chinese, Turkish, Ukrainian, Urdu, Zulu
Recent release
2.6.2 (1 month ago )
Released on
Apr 7, 2021 (3 years ago )
Last Updated
1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.